Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delafloxacin vs Vancomycin or Linezolid in ABSSSI
NCT01283581Phase 2Completed
- Sponsor
- Melinta Therapeutics
- Start
- Jan 2011
- Primary completion
- Nov 2011
- Countries
- 1
01
Overview
A Phase 2 trial of delafloxacin in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Melinta Therapeutics. Started Jan 2011; status: completed.
02
Drugs
delafloxacin
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT01283581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283581.